Finding the Path in Eosinophilic Esophagitis
Interdisciplinary Strategies for Adult and Pediatric Patients
Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the Consortium for Food Allergy Research.
Chehade M, et al. J Allergy Clin Immunol Pract. 2018;6(5):1534-1544.e5
Mechanisms of disease of eosinophilic esophagitis.
Davis BP, Rothenberg ME. Annu Rev Pathol. 2016;11:365-393.
A phase 3, randomized, 3-part study to investigate the efficacy and safety of dupilumab in adult and adolescent patients with eosinophilic esophagitis: results from part A.
Dellon ES. American College Gastroenterology Conference. October 26, 2020. Abstract LB3.
Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial.
Hirano I, et al. Clin Gastroenterol Hepatol. 2021. doi: 10.1016/j.cgh.2021.04.022. [Epub ahead of print.]
Effects of race and sex on features of eosinophilic esophagitis.
Moawad FJ, et al. Clin Gastroenterol Hepatol. 2016;14(1):23-30.
Dietary therapy for eosinophilic esophagitis.
Molina-Infant J, Lucendo AJ. J Allergy Clin Immunol. 2018;142(1):41-47.
Eosinophilic esophagitis: a review.
Muir A, Falk GW. JAMA. 2021.326(13):1310-1318.
Pathophysiology of eosinophilic esophagitis.
O’Shea KM, et al. Gastroenterology. 2018;154(2):333-345
Medical algorithm: diagnosis and treatment of EoE in children.
Spergel JM, et al. Allergy. 2020;75(6):1522-1524.
Guidelines
Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference.
Dellon ES, et al. Gastroenterol. 2018;155(4):1022-1033.e10
AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.
Hirano I, et al. Gastroenterology. 2020;158(6):1776-1786.
Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters.
Rank MA, et al. Ann Allergy Asthma Immunol 2020;124(5):424-440.e17
